MapLight Therapeutics

Verified by our team

  • Biotech
Linkedin Twitter Facebook

Maplight is a biopharmaceutical company developing novel therapeutics for patients with central nervous system (CNS) disorders, including Autism Spectrum Disorder, Parkinson’s Disease, and Schizophrenia.

MapLight Therapeutics Highlights:

  • MapLight Therapeutics annual revenue is $12.7M.
  • MapLight Therapeutics total funding is $305.0M.
  • MapLight Therapeutics headquartered in Palo Alto, California.
  • MapLight Therapeutics number of employees is 82.

    • Overview

    • Website: maplightrx.com
    • Headquarters: Palo Alto, California
    • Employees: 82
    • Founded: 2018
    • Email: info@maplightrx.com
    • Funding: $305.0M
    • Revenue: $12.7M
    • Valuation: n/a

    Contacts

    Chris Kroeger

    CEO
    Linkedin
    • Email: ***@maplightrx.com
    Buy the List to Unlock Contacts

    Similar companies

    Frequently Asked Questions related to MapLight Therapeutics

    MapLight Therapeutics is located in Palo Alto, California.
    Yes, MapLight Therapeutics is a Silicon Valley company.
    MapLight Therapeutics total funding is 305.0M.
    MapLight Therapeutics revenue is 12.7M.
    MapLight Therapeutics’s number of employees is 82.
    MapLight Therapeutics’s CEO name is Chris Kroeger.
    MapLight Therapeutics was founded in 2018.
    MapLight Therapeutics’s contact email is info@maplightrx.com.

    Follow Silicon Valley Journals

    Awarded by

    corporate vision magazine

    © Copyright 2022-2024 Silicon Valley Journals. All rights reserved.

    Fundings

    Quick links

    Company

    © Copyright SVJ Media Ltd., 71-75 Shelton Street. Covent Garden. London, GB WC2H 9JQ